Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bin Qin
Observed names:
Bin, Qin,
Qin Bin,
Qin, Bin
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0008-0078-9503
Observed ORCID:
0009-0008-0078-9503
OpenAlex ID:
A5133052901
Mastering particle size analysis: lessons, challenges, and future directions from the FDA–CRCG workshop
2026
·
Xiaoming Xu
, William C. Smith
, et al.
·
AAPS Open
·
4
PDF
Impact of ionizable lipid source on quality and stability of siRNA-loaded lipid nanoparticles
2026
·
Sheyda Ranjbar
, Kuo-Chih Shih
, et al.
·
Journal of Controlled Release
·
3
In vitro, ex vivo, and in vivo evaluation of ophthalmic ointments containing dexamethasone and tobramycin
2025
·
Catheleeya Mekjaruskul
, Andre O'Reilly Beringhs
, et al.
·
International Journal of Pharmaceutics X
·
2
Computed Tomography Imaging and Characteristics of In Situ Forming Implants with Different PLGA Endcaps.
2026
·
Zouabi, Nour Al
, Zhang, Qiangnan
, et al.
·
UNC Libraries
Impact of Mixing Approach and Bubble Formation on In Situ Forming Implant Properties
2026
·
Xinhao Lin
, Seyyed Majid Eslami
, et al.
·
Pharmaceutical Research
Mastering particle size analysis: lessons, challenges, and future directions from the FDA–CRCG workshop
2026
·
Xu, Xiaoming
, Smith, William C.
, et al.
·
Figshare
Show more works
View as search
Works count:
7
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type